|

Eltrombopag Clinical Trials

3 actively recruiting trials

Also known as: promacta

Pipeline

Phase 2: 1Phase 4: 1

Top Sponsors

  • Wei Zhao1
  • Sohag University1
  • Institute of Hematology & Blood Diseases Hospital, China1

Indications

  • Cancer2
  • ITP - Immune Thrombocytopenia1
  • Liver Disease1
  • Hematological Neoplasms1
  • Eltrombopag1

Other3 trials

Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
Phase 4
Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
N/A
Eltrombopag for Chemotherapy-induced Thrombocytopenia
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.